Acurx Pharmaceuticals, Inc. (Nasdaq ACXP) (“Acurx” or the “Company”), a clinical-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.